Listed

Collegium Pharmaceutical, Inc: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 11, 2016 and accepted by EDGAR at Aug 11, 2016, 16:42 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2016-04-01 to 2016-06-30$4.3mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-01-01 to 2016-06-30$8.4mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-04-01 to 2016-06-30−$24.5mus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30−$40.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-04-01 to 2016-06-30$46.0kus-gaap:InterestExpense
Interest expense6 months2016-01-01 to 2016-06-30$111.0kus-gaap:InterestExpense
Net income3 months2016-04-01 to 2016-06-30−$24.5mus-gaap:NetIncomeLoss
Net income6 months2016-01-01 to 2016-06-30−$40.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-04-01 to 2016-06-30−$1.05us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30−$1.73us-gaap:EarningsPerShareBasicAndDiluted
Basic EPS3 months2016-04-01 to 2016-06-30−$1.05us-gaap:EarningsPerShareBasic
Basic EPS6 months2016-01-01 to 2016-06-30−$1.73us-gaap:EarningsPerShareBasic
Operating cash flow6 months2016-01-01 to 2016-06-30−$32.4mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2016-01-01 to 2016-06-30$25.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-06-30$110.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-06-30$116.5mus-gaap:AssetsCurrent
Total assetsAt period end2016-06-30$119.7mus-gaap:Assets
Current liabilitiesAt period end2016-06-30$18.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-06-30$21.1mus-gaap:Liabilities
Shareholders' equityAt period end2016-06-30$98.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-16-007925. Last ingested by Listed: Nov 10, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.